Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record.

Relaxin: Exploring the antifibrotic potential of a pregnancy hormone

Open access
Gaedeke, Jens, Peters, Harm·2005·Kidney International

Abstract

Excess accumulation of extracellular matrix proteins has been well recognized as a key feature of chronic kidney diseases. Renal fibrosis, particularly tubulointerstitial fibrosis, parallels the progressive loss of organ function, which ultimately leads to overt renal failure and the need for dialysis. Driven by distinct causes like hypertension, chronic inflammation, elevated blood glucose, or postrenal obstruction, development of kidney fibrosis is mediated and fine-tuned by a variety of cytokines, growth factors, and soluble factors. Among others, transforming growth factor-beta (TGF-b) is of pivotal importance because of its ability to regulate both matrix protein synthesis and degradation in a distinctive profibrotic manner. As the knowledge about TGF-b and matrix protein biology and pathophysiology has substantially increased over the recent years, new strategies to tackle renal fibrosis have been developed that are centered around the cascade of TGF-b generation, TGF-b signaling, and matrix protein deposition and degradation. An emerging novel therapeutic approach to target fibrosis is relaxin, a small peptide hormone that is endogenously produced by corpus luteum of the ovary. The name relaxin is derived from its unique ability to soften connective tissue of the reproductive tract in pregnancy (i.e., to relax the cervix and the pubic ligament to facilitate delivery) [1]. Relaxin has received additional interest because it mediates the profound vascular effects seen in pregnancy, too. The general hemodynamic changes and, especially, the changes in renal hemodynamics in pregnancy (decline in renal vascular resistance, increase in renal plasma flow and GFR) are mediated in large parts by relaxin through actions on nitric oxide and endothelin receptor B activation [1, 2]. Of particular interest to nephrologists, relaxin blocks the renal hemodynamic effects of angiotensin II independently of pregnancy [3]. These vascular effects appear largely dependent on the activation of matrix-metalloproteases (MMP), enzymes that digest and remove collagens and other matrix proteins [1, 2, 4]. Activation of MMPs by relaxin has been

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1523-1755.2005.00462.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 179

Metadata

Authors
Gaedeke, J., & Peters, H.
Venue
Kidney International
Publisher
Elsevier BV
Published
2005-07
Volume
68
Issue
1
Pages
405-406
ISSN
0085-2538 (ISSN-L)
OpenAlex
W1512015690
Cited by
179
References
0
FWCI
7.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relaxin: Exploring the antifibrotic potential of a pregnancy hormone. https://app.cochat.ai/papers/10.1111/j.1523-1755.2005.00462.x
The paper
Gaedeke, J., & Peters, H. (2005). Relaxin: Exploring the antifibrotic potential of a pregnancy hormone. Kidney International. https://doi.org/10.1111/j.1523-1755.2005.00462.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.